Multiple synchronous lung cancers and atypical adenomatous hyperplasia in Li-Fraumeni syndrome

被引:15
作者
Nadav, Y
Pastorino, U
Nicholson, AG
机构
[1] Royal Brompton Hosp, Dept Histopathol, London SW3 6NP, England
[2] Royal Brompton Hosp, Dept Surg, London SW3 6NP, England
关键词
adenocarcinoma; atypical adenomatous hyperplasia; Li-Fraumeni syndrome; multiple tumours; p53;
D O I
10.1046/j.1365-2559.1998.00439.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aim: We report a patient with Li-Fraumeni syndrome who developed multiple synchronous primary lung cancers together with atypical adenomatous hyperplasia, and discuss the pathogenesis of the lesions, Case details: A 57-year-old woman with Li-Fraumeni syndrome and a history of smoking was diagnosed as having multiple synchronous primary lung tumours, all of which were treated by surgical excision. Histological examination showed three separate well-differentiated adenocarcinomas and a single focus of atypical adenomatous hyperplasia, A constitutional mutation of the p53 gene had been identified, both in this patient and other members of her family. Conclusion: Multiple synchronous primary lung tumours have not been reported before in association with this syndrome. With both smoking and Li-Fraumeni syndrome known to be associated with mutations in the p53 suggested in this patient.
引用
收藏
页码:52 / 54
页数:3
相关论文
共 9 条
[1]  
BIRCH JM, 1994, CANCER RES, V54, P1298
[2]   Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53 [J].
Denissenko, MF ;
Pao, A ;
Tang, MS ;
Pfeifer, GP .
SCIENCE, 1996, 274 (5286) :430-432
[3]  
EELES RA, 1993, ONCOGENE, V8, P1269
[4]  
KERR KM, 1997, PATHOLOGY LUNG TUMOR, P119
[5]   GERM LINE P53 MUTATIONS IN A FAMILIAL SYNDROME OF BREAST-CANCER, SARCOMAS, AND OTHER NEOPLASMS [J].
MALKIN, D ;
LI, FP ;
STRONG, LC ;
FRAUMENI, JF ;
NELSON, CE ;
KIM, DH ;
KASSEL, J ;
GRYKA, MA ;
BISCHOFF, FZ ;
TAINSKY, MA ;
FRIEND, SH .
SCIENCE, 1990, 250 (4985) :1233-1238
[6]   P53 AND THE LI-FRAUMENI SYNDROME [J].
MALKIN, D .
CANCER GENETICS AND CYTOGENETICS, 1993, 66 (02) :83-92
[7]   THE VALUE OF PE-10, A MONOCLONAL-ANTIBODY AGAINST PULMONARY SURFACTANT, IN DISTINGUISHING PRIMARY AND METASTATIC LUNG-TUMORS [J].
NICHOLSON, AG ;
MCCORMICK, CJ ;
SHIMOSATO, Y ;
BUTCHER, DN ;
SHEPPARD, MN .
HISTOPATHOLOGY, 1995, 27 (01) :57-60
[8]   MULTIPLE PRIMARY LUNG CARCINOMAS - PROGNOSIS AND TREATMENT [J].
ROSENGART, TK ;
MARTINI, N ;
GHOSN, P ;
BURT, M .
ANNALS OF THORACIC SURGERY, 1991, 52 (04) :773-779
[9]   2ND PRIMARY LUNG-CANCER - IMPORTANCE OF LONG-TERM FOLLOW UP [J].
VANBODEGOM, PC ;
WAGENAAR, SS ;
CORRIN, B ;
BAAK, JPA ;
BERKEL, J ;
VANDERSCHUEREN, RGJRA .
THORAX, 1989, 44 (10) :788-793